Judith Hurley

3.6k total citations
74 papers, 2.3k citations indexed

About

Judith Hurley is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Judith Hurley has authored 74 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 31 papers in Cancer Research and 17 papers in Genetics. Recurrent topics in Judith Hurley's work include Breast Cancer Treatment Studies (27 papers), Cancer Treatment and Pharmacology (18 papers) and BRCA gene mutations in cancer (12 papers). Judith Hurley is often cited by papers focused on Breast Cancer Treatment Studies (27 papers), Cancer Treatment and Pharmacology (18 papers) and BRCA gene mutations in cancer (12 papers). Judith Hurley collaborates with scholars based in United States, Canada and Bahamas. Judith Hurley's co-authors include Stephen P. Richman, Isildinha M. Reis, Vicente Valero, Tito R. Mendoza, Guadalupe R. Palos, Charles S. Cleeland, Karen O. Anderson, Stefan Glück, Mark D. Pegram and Carmen Gomez‐Fernandez and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Judith Hurley

70 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Judith Hurley United States 24 1.1k 646 441 347 343 74 2.3k
Corrado Ficorella Italy 27 1.2k 1.1× 419 0.6× 241 0.5× 371 1.1× 200 0.6× 140 2.6k
Daniel E. Kenady United States 28 1.8k 1.7× 364 0.6× 190 0.4× 154 0.4× 247 0.7× 111 3.6k
Anke Bergmann Brazil 28 1.5k 1.4× 349 0.5× 461 1.0× 63 0.2× 298 0.9× 221 2.8k
Anna K.L. Reyners Netherlands 29 1.0k 0.9× 346 0.5× 313 0.7× 68 0.2× 160 0.5× 129 2.5k
Paul Craft Australia 23 653 0.6× 377 0.6× 295 0.7× 41 0.1× 161 0.5× 43 1.6k
Marianna Koczywas United States 33 2.0k 1.8× 243 0.4× 831 1.9× 208 0.6× 138 0.4× 135 3.9k
Hong Guo China 25 441 0.4× 272 0.4× 263 0.6× 105 0.3× 99 0.3× 99 1.9k
John H. Fetting United States 28 1.6k 1.5× 693 1.1× 497 1.1× 32 0.1× 224 0.7× 73 3.2k
Erik Wist Norway 28 1.3k 1.2× 383 0.6× 214 0.5× 58 0.2× 98 0.3× 59 2.6k
Katherine Clark Australia 20 567 0.5× 402 0.6× 616 1.4× 104 0.3× 80 0.2× 87 2.2k

Countries citing papers authored by Judith Hurley

Since Specialization
Citations

This map shows the geographic impact of Judith Hurley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith Hurley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith Hurley more than expected).

Fields of papers citing papers by Judith Hurley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith Hurley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith Hurley. The network helps show where Judith Hurley may publish in the future.

Co-authorship network of co-authors of Judith Hurley

This figure shows the co-authorship network connecting the top 25 collaborators of Judith Hurley. A scholar is included among the top collaborators of Judith Hurley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith Hurley. Judith Hurley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schlumbrecht, Matthew, et al.. (2025). Differences in breast cancer outcomes amongst Caribbean born women in Florida, USA—a population-based analysis. The Lancet Regional Health - Americas. 52. 101292–101292.
2.
O’Neil, Daniel S., Yehoda M. Martei, Katherine D. Crew, et al.. (2023). Time to Cancer Treatment and Chemotherapy Relative Dose Intensity for Patients With Breast Cancer Living With HIV. JAMA Network Open. 6(12). e2346223–e2346223. 1 indexed citations
3.
Dezem, Felipe Segato, Judith Hurley, Carmen Gómez, et al.. (2023). A machine learning one-class logistic regression model to predict stemness for single cell transcriptomics and spatial omics. BMC Genomics. 24(1). 717–717. 4 indexed citations
4.
Bagherzadeh, Maryam, Agata Szymiczek, Talia Donenberg, et al.. (2020). Association of RAD51C germline mutations with breast cancer among Bahamians. Breast Cancer Research and Treatment. 184(2). 649–651. 5 indexed citations
5.
Vargas, Fernando, et al.. (2019). Complications of Intrathecal Chemotherapy in Adults: Single-Institution Experience in 109 Consecutive Patients. Journal of Oncology. 2019. 1–7. 32 indexed citations
6.
Schlumbrecht, Matthew, et al.. (2019). Differences in breast cancer outcomes amongst Black US-born and Caribbean-born immigrants. Breast Cancer Research and Treatment. 178(2). 433–440. 19 indexed citations
7.
Lerner‐Ellis, Jordan, Talia Donenberg, Sophia George, et al.. (2017). A high frequency of PALB2 mutations in Jamaican patients with breast cancer. Breast Cancer Research and Treatment. 162(3). 591–596. 8 indexed citations
8.
Wright, Jean L., Kunal Saigal, Isildinha M. Reis, et al.. (2015). Locoregional and Overall Recurrence After Neaodjuvant Endocrine Therapy Versus Chemotherapy in Postmenopausal Women With Estrogen Receptor+ HER2− Breast Cancer. American Journal of Clinical Oncology. 40(5). 490–497. 8 indexed citations
9.
Hurley, Judith, Isildinha M. Reis, Steven E. Rodgers, et al.. (2013). The use of neoadjuvant platinum-based chemotherapy in locally advanced breast cancer that is triple negative: retrospective analysis of 144 patients. Breast Cancer Research and Treatment. 138(3). 783–794. 64 indexed citations
10.
Wright, Jean L., Cristiane Takita, Isildinha M. Reis, et al.. (2012). Predictors of locoregional outcome in patients receiving neoadjuvant therapy and postmastectomy radiation. Cancer. 119(1). 16–25. 32 indexed citations
11.
Hurley, Judith, et al.. (2011). Impact of urgent suspected cancer (USC) versus non-USC referral pathways on survival of upper GI cancers: Figure 1. Gut. 60(Suppl 1). A13.2–A14. 2 indexed citations
12.
Donenberg, Talia, John Lunn, Theodore Turnquest, et al.. (2010). A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas. Breast Cancer Research and Treatment. 125(2). 591–596. 58 indexed citations
13.
Lobo, Christopher, Gilberto Lopes, Aurelio Castrellon, et al.. (2010). Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer. Breast Cancer Research and Treatment. 123(2). 427–435. 68 indexed citations
14.
Yang, Relin, Michael C. Cheung, Dido Franceschi, et al.. (2009). African-American and Low–Socioeconomic Status Patients Have a Worse Prognosis for Invasive Ductal and Lobular Breast Carcinoma: Do Screening Criteria Need to Change?. Journal of the American College of Surgeons. 208(5). 853–868. 15 indexed citations
15.
16.
Hurley, Judith, Isildinha M. Reis, Orlando Silva, et al.. (2006). Docetaxel, Cisplatin, and Trastuzumab As Primary Systemic Therapy for Human Epidermal Growth Factor Receptor 2–Positive Locally Advanced Breast Cancer. Journal of Clinical Oncology. 24(12). 1831–1838. 186 indexed citations
17.
Hernandez‐Reif, Maria, Tiffany Field, Gail Ironson, et al.. (2005). NATURAL KILLER CELLS AND LYMPHOCYTES INCREASE IN WOMEN WITH BREAST CANCER FOLLOWING MASSAGE THERAPY. International Journal of Neuroscience. 115(4). 495–510. 85 indexed citations
18.
Lee, Young Jae, et al.. (2004). Docetaxel and Cisplatin as Primary Chemotherapy for Treatment of Locally Advanced Breast Cancers. Clinical Breast Cancer. 5(5). 371–376. 24 indexed citations
19.
Feun, Lynn G., et al.. (2002). Phase II Trial of Paclitaxel and Dacarbazine with Filgrastim Administration in Advanced Malignant Melanoma. Cancer Investigation. 20(3). 357–361. 5 indexed citations
20.
Lee, Yong J., Judith Hurley, Carolyn Mies, et al.. (1998). A phase II trial of neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of patients with locally advanced breast carcinoma. Cancer. 82(3). 503–511. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Corrado Ficorella Breakdown of academic impact, for papers by Daniel E. Kenady Breakdown of academic impact, for papers by Anke Bergmann Breakdown of academic impact, for papers by Anna K.L. Reyners Breakdown of academic impact, for papers by Paul Craft Breakdown of academic impact, for papers by Marianna Koczywas Breakdown of academic impact, for papers by Hong Guo Breakdown of academic impact, for papers by John H. Fetting Breakdown of academic impact, for papers by Erik Wist Breakdown of academic impact, for papers by Katherine Clark
Rankless by CCL
2026